Term
|
Definition
Brand: Thorazine
First Generation, low potency |
|
|
Term
|
Definition
Brand: Mellaril
FGA, low potency |
|
|
Term
|
Definition
Brand: Loxitane
FGA, medium potency |
|
|
Term
|
Definition
Brand: Trilafon
FGA, medium potency |
|
|
Term
|
Definition
Brand: Navane
FGA, medium potency |
|
|
Term
|
Definition
Brand: Stelazine
FGA, high potency |
|
|
Term
|
Definition
Brand: Prolixin, Prolixin Decanoate
FGA, high potency |
|
|
Term
|
Definition
Brand: Haldol, Haldol decanoate
FGA, high potency |
|
|
Term
|
Definition
Brand: Clozaril, Fazaclo
SGA, low potency, higher risk for hypotension and sedation |
|
|
Term
|
Definition
Brand: Zyprexa
SGA, low potency |
|
|
Term
|
Definition
Brand: Seroquel
SGA, low potency |
|
|
Term
|
Definition
Brand: Risperdal, Risperdal consta
SGA, high potency, highest risk for hyperprolactinemia |
|
|
Term
|
Definition
Brand: Invega, Invega sustenna
SGA, high potency, highest risk for hyperprolactinemia |
|
|
Term
|
Definition
Brand: Fanapt
SGA, medium potency
*Highest risk for hypotension |
|
|
Term
|
Definition
Brand: Saphris
SGA, medium potency, NO FOOD |
|
|
Term
|
Definition
Brand: Geodon
SGA, medium potency, high risk for QTc prolongation, take with food |
|
|
Term
|
Definition
Brand: Latuda
SGA, medium potency, must be taken with food |
|
|
Term
|
Definition
Brand: Abilify, Anilify maintena
SGA, medium potency, most activiating, akathisia risk, partial D2 agonist |
|
|
Term
|
Definition
Brand: Rexulti
SGA, medium potency, partial D2 agonist, akathisia risk |
|
|
Term
|
Definition
Brand: Vraylar
SGA, medium potency, partial D2 agonist, risk of akathisia |
|
|
